Magma is a modern hybrid strain with a lineage that remains thinly documented and largely unconfirmed. Breeders have not publicly verified the specific cross, and the history of its development is not formally recorded. Because its precise origins are undocumented, it is categorized as a modern variety that lacks a clear ancestral record, distinguishing it from established heirlooms or landrace strains. Despite this lack of historical transparency, the strain has achieved recognition for its performance in both indoor and outdoor cultivation environments, where it maintains a moderate level of difficulty and is capable of producing a high yield within a 56-day flowering cycle.

The chemical profile of Magma features a confirmed arrangement of dominant to tertiary terpenes, led by caryophyllene and followed by myrcene, linalool, limonene, humulene, beta-pinene, pinene, and nerolidol. This composition suggests a complex sensory experience, though its potency figures remain an estimate; the strain reportedly contains an estimated 16.2% THC and an estimated 0.04% CBD. Users should expect a nuanced aromatic profile shaped by the prominent presence of caryophyllene and myrcene, with further botanical depth provided by the subsequent linalool and limonene content.

Magma is primarily sought for its ability to induce effects that are consistently reported as relaxed, happy, and uplifted. These characteristics make it a functional choice for addressing concerns related to stress, pain, and sleep. While its practical applications are targeted toward these user needs, there are currently no notable offshoot strains recorded or attributed to its genetic line. The strain serves as a consistent option for those prioritizing specific therapeutic outcomes over a highly publicized or distinctive lineage.